These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 18678911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.
    Virology; 2005 Sep 01; 339(2):164-75. PubMed ID: 15993917
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge.
    Nigam P, Earl PL, Americo JL, Sharma S, Wyatt LS, Edghill-Spano Y, Chennareddi LS, Silvera P, Moss B, Robinson HL, Amara RR.
    Virology; 2007 Sep 15; 366(1):73-83. PubMed ID: 17507071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
    Kennedy JS, Gurwith M, Dekker CL, Frey SE, Edwards KM, Kenner J, Lock M, Empig C, Morikawa S, Saijo M, Yokote H, Karem K, Damon I, Perlroth M, Greenberg RN.
    J Infect Dis; 2011 Nov 15; 204(9):1395-402. PubMed ID: 21921208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.
    Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R.
    J Infect Dis; 2010 May 01; 201(9):1353-60. PubMed ID: 20350190
    [Abstract] [Full Text] [Related]

  • 11. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
    Davies DH, Wyatt LS, Newman FK, Earl PL, Chun S, Hernandez JE, Molina DM, Hirst S, Moss B, Frey SE, Felgner PL.
    J Virol; 2008 Jan 01; 82(2):652-63. PubMed ID: 17977963
    [Abstract] [Full Text] [Related]

  • 12. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
    Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, Hornung J, Weidenthaler H, Heery CR, Meyer TPH, Silbernagl G, Maclennan J, Chaplin P.
    N Engl J Med; 2019 Nov 14; 381(20):1897-1908. PubMed ID: 31722150
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.
    Garza NL, Hatkin JM, Livingston V, Nichols DK, Chaplin PJ, Volkmann A, Fisher D, Nalca A.
    Vaccine; 2009 Sep 04; 27(40):5496-504. PubMed ID: 19632316
    [Abstract] [Full Text] [Related]

  • 15. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.
    McCurdy LH, Rutigliano JA, Johnson TR, Chen M, Graham BS.
    J Virol; 2004 Nov 04; 78(22):12471-9. PubMed ID: 15507634
    [Abstract] [Full Text] [Related]

  • 16. Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAs.
    Hermanson G, Chun S, Felgner J, Tan X, Pablo J, Nakajima-Sasaki R, Molina DM, Felgner PL, Liang X, Davies DH.
    Vaccine; 2012 Jan 11; 30(3):614-25. PubMed ID: 22100890
    [Abstract] [Full Text] [Related]

  • 17. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
    Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh S.
    J Virol; 2007 Aug 11; 81(16):8774-83. PubMed ID: 17553867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A, Baljer G, Wagner C, Sailer J.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr 11; 259(2):206-18. PubMed ID: 2990123
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO.
    Vaccine; 2007 Jan 02; 25(1):34-42. PubMed ID: 16950548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.